Whitehawk Therapeutics WHWK
NASDAQ WHWK
$3.70 -0.06 (-1.60%)
At close: Oct 2, 2026 · 4:00 PM EDT

Whitehawk Therapeutics (WHWK) Return on Capital Employed [ROCE] (2017 - 2026)

Updated

Whitehawk Therapeutics (WHWK) recorded Return on Capital Employed [ROCE] of -57.55% in Q2 2026, down 6.04 percentage points from -51.51% a year earlier but up 38.33 percentage points from the prior quarter.

Analysis

Whitehawk Therapeutics (WHWK) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends

For FY2025, Whitehawk Therapeutics reported Return on Capital Employed [ROCE] of -119.10%, down 39.07 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three straight years, though with a four-year change of +33.06 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -80.02% in FY2024 (-25.50 pp), -54.52% in FY2023 (-13.35 pp), -41.17% in FY2022 (+110.98 pp) and -152.16% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has ranged from -110.71% in Q4 2024 to -36.80% in Q4 2022 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in four of the last eight quarters, with an average year-over-year change of -2.53 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 65.01 percentage points in Q2 2023, against a drop of 329.98 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at -95.88% (Q1 2026), -79.22% (Q4 2025) and -66.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Whitehawk Therapeutics 306.68 Mn 306.68 Mn - -57.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.55%
Mar 31, 2026 -95.88%
Dec 31, 2025 -79.22%
Sep 30, 2025 -66.11%
Jun 30, 2025 -51.51%
Mar 31, 2025 -45.15%
Dec 31, 2024 -110.71%
Sep 30, 2024 -85.07%
Jun 30, 2024 -83.92%
Mar 31, 2024 -73.25%
Dec 31, 2023 -65.60%
Sep 30, 2023 -55.79%
Jun 30, 2023 -45.20%
Mar 31, 2023 -41.14%
Dec 31, 2022 -36.80%
Sep 30, 2022 -44.02%
Jun 30, 2022 -110.21%
Mar 31, 2022 -87.26%
Dec 31, 2021 -75.11%
Sep 30, 2021 -94.91%
API Access

Whitehawk Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=WHWK&period=max&api_key=YOUR_API_KEY